Press Releases
Representative Sharice Davids issued the following statement on the decision to self-quarantine after having contact with a member of Congress who later tested positive for the coronavirus:
Representative Sharice Davids issued the following statement in response to new testing guidelines released by the Kansas Department of Health and Environment that reduce coronavirus testing in Johnson County, which has the most confirmed cases of the coronavirus:
Representative Sharice Davids issued the following statement on House passage of the Families First Coronavirus Response Act, which bolsters the federal government's response to the coronavirus outbreak:
Today, Representative Sharice Davids sent the following update to constituents of Kansas' Third District about COVID-19 and changes in her Washington, D.C. office and District offices.
The full letter can be found here. An excerpt is below:
Representative Sharice Davids issued on the following statement on the first COVID-19 related death in Kansas:
Representative Sharice Davids issued the following statement on news of three additional presumptive positive cases of COVID-19 in Johnson County:
As public health professionals work to contain the spread of coronavirus, Representative Sharice Davids outlined steps that Congress, as well as Kansas' legislature, could take today to protect the livelihood of workers, families and small businesses across the United States.
During a House Small Business Committee hearing today, Representative Sharice Davids examined the impact of the coronavirus on Kansas' small businesses and discussed additional measures Congress could take to offset economic hardship for workers and businesses.
Representative Sharice Davids issued the following statement on House passage of a coronavirus emergency response supplemental funding bill:
Today, Representative Sharice Davids introduced the Transparency in Prescription Drug Advertising Act, which would require pharmaceutical companies to include the list prices of their prescription drugs in all direct-to-consumer (DTC) advertisements. This legislation holds pharmaceutical companies accountable for their prices, especially as the cost of prescription drugs continues to rise.